Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinxing Mihuan oral solution for chest pain after PCI
ChiCTR2000028760Phase 4Recruiting
- Sponsor
- Fuwai Hospital
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Yinxingmihuan in coronary arteriosclerosis and Post-PCI chest pain (PPCP) (2 arms), sponsored by Fuwai Hospital. Primary endpoint: Seattle Angina Questionnaire score at week 20. Started Jan 2019; status: recruiting.
02
Drugs
Yinxingmihuan
03
Conditions
coronary arteriosclerosisPost-PCI chest pain (PPCP)
Beyond the preview
Go deeper on ChiCTR2000028760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028760.